Compare DLB & TFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DLB | TFX |
|---|---|---|
| Founded | 1965 | 1943 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Multi-Sector Companies | Medical/Dental Instruments |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 5.8B |
| IPO Year | 2004 | 1994 |
| Metric | DLB | TFX |
|---|---|---|
| Price | $60.93 | $141.23 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 8 |
| Target Price | $90.75 | ★ $138.75 |
| AVG Volume (30 Days) | ★ 949.4K | 407.6K |
| Earning Date | 04-30-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.28% | 1.02% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.84 | N/A |
| Revenue | N/A | ★ $1,992,713,000.00 |
| Revenue This Year | $6.22 | $15.97 |
| Revenue Next Year | $3.84 | $5.15 |
| P/E Ratio | $32.46 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $48.26 | $100.18 |
| 52 Week High | $75.66 | $144.19 |
| Indicator | DLB | TFX |
|---|---|---|
| Relative Strength Index (RSI) | 69.58 | N/A |
| Support Level | $57.62 | N/A |
| Resistance Level | $65.73 | N/A |
| Average True Range (ATR) | 1.53 | 0.00 |
| MACD | 1.24 | 0.00 |
| Stochastic Oscillator | 83.75 | 0.00 |
Dolby Laboratories Inc. develops technologies that enhance audio and video capture, transmission, and playback, enabling high-quality experiences across movies, TV, music, sports, and more. The company designs and manufactures audio, imaging, accessibility, and related hardware and software mainly for cinema, including digital cinema servers and media encryption and packaging tools. It generates the majority of its revenue by licensing its technology, brand, and patents to device manufacturers and by selling cinema hardware and services. It operates as a single reportable segment, with revenue derived mainly from licensing and, to a lesser extent, from premium cinema technologies, across the United States and international markets.
Teleflex Inc is a provider of medical technology products focused on enhancing clinical benefits, improving patient and provider safety and reducing total procedural costs. It designs, develops, manufactures and supply medical devices used by hospitals and healthcare providers supporting high-acuity emergent procedures. The company has three reportable segments: Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). It derives maximum revenue from Americas. Its products includes: Anaesthesia, Emergency Medicine, Interventional Cardiology/Radiology, Interventional Urology - UroLift System, Surgery, Urology, and Vascular Access.